期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 22, 期 16, 页码 -出版社
MDPI
DOI: 10.3390/ijms22168926
关键词
vitamin D; scleroderma; TGF-beta 1; bleomycin model of fibrosis; collagen; cytokines
资金
- National Scleroderma Foundation
- Arthritis Foundation
- Department of Veterans Affairs Merit Review Grant
- National Institutes of Health [R21AR066505, 1R01AR071189-01A1, 1R01AR073004-01A1, R21 AI149267-01A1]
- Department of Veterans Affairs Merit Review Grant [1I01BX004293-01A1]
- University of Tennessee College of Pharmacy Drug Discovery Center
- [5IP1BX001607-01]
The study shows that the noncalcemic vitamin D analog, 17,20S(OH)(2)pD, can suppress total collagen production, dermal thickness, and total collagen content in a fibrosis model, while also increasing MMP-13 expression and decreasing expression of other related factors, as well as suppressing certain cytokines in the serum. This antifibrotic property offers new therapeutic approaches for fibrotic disorders.
Systemic sclerosis (SSc; scleroderma) is a chronic fibrotic disease involving TGF-beta 1. Low serum vitamin D (vit D) correlates with the degree of fibrosis and expression of TGF-beta 1. This study was designed to determine whether the noncalcemic vit D analog, 17,20S(OH)(2)pD, suppresses fibrosis and mediators of the TGF-beta 1 pathway in the bleomycin (BLM) model of fibrosis. Fibrosis was induced into the skin of female C57BL/6 mice by repeated injections of BLM (50 mu g/100 mu L) subcutaneously. Mice received daily oral gavage with either vehicle (propylene glycol) or 17,20S(OH)(2)pD using 5, 15, or 30 mu g/kg for 21 days. The injected skin was biopsied; analyzed histologically; examined for total collagen by Sircol; and examined for mRNA expression of MMP-13, BMP-7, MCP-1, Gli1, and Gli2 by TR-PCR. Spleen was analyzed for lymphocytes using flow cytometry. Serum was analyzed for cytokines using a multiplexed ELISA. Results showed that all three doses of 17,20S(OH)(2)pD suppressed net total collagen production, dermal thickness, and total collagen content in the BLM fibrosis model. 17,20S(OH)(2)pD also increased MMP-13 expression, decreased MCP-1 and Gli-2 expression in vivo, and suppressed serum levels of IL-13, TNF-alpha, IL-6, IL-10, IL-17, and IL-12p70. In summary, 17,20S(OH)(2)pD modulates the mediators of fibrosis in vivo and suppresses total collagen production and dermal thickness. This antifibrotic property of 17,20S(OH)(2)pD offers new therapeutic approaches for fibrotic disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据